Home     About Us     Medic-All     Bio B2B     Hot Topic     Expo     Login | Join Now     Search Button
 Taiwan Healthcare+ Expo
 Witness Asia’s healthcare transformation and create unprecedented opportunities with global healthcare players. Taiwan Healthcare+ Expo provides a stage for interdisciplinary collaborations between medicine, IT/electronics, pharmaceuticals, and biotech to foster medical technology innovations. It is the signature expo in Asia Pacific that strategically connects all health-related sectors from all over the world together in one place.
 Taiwan Healthcare+ Expo
 Witness Asia’s healthcare transformation and create unprecedented opportunities with global healthcare players. Taiwan Healthcare+ Expo provides a stage for interdisciplinary collaborations between medicine, IT/electronics, pharmaceuticals, and biotech to foster medical technology innovations. It is the signature expo in Asia Pacific that strategically connects all health-related sectors from all over the world together in one place.
2018 Registration for Professionals
 Med x Tech Summit Asia
B2B partnering
Concurrent Conference
 Exhibitor Highlights: 1.World-class medical institutes and advanced medical technologies 2. Leading IT, ICT, electronics and tech giants & comprehensive digital healthcare supply chain 3. Innovative medical AI, IoT and robotic technologies 4.  High-quality bio-pharmaceutical R&D, CDMO and CMO companies 5. Efficient genetic testing, laboratory services and solutions 6. New business models for preventive medicine and healthcare management
 Med x Tech Summit Asia: 1.Keynote Speakers: Hitachi、IBM Watson Health、illumina、Nvidia、Microsoft、Google & Verily、Merck、Novartis、Teva、Takeda、Bluebird Bio、Nebula Genomics 2. CEO Forum: Global industry leaders will discuss the future trends of the healthcare industry from various perspectives. Opportunities and strategies for biomedical developments and investments will be explored in depth. 3. Intelligent Healthcare Conference: This international conference gathers world-leading professionals from different industries, government, and academia to explore the unprecedented power of interdisciplinary collaborations between medicine and technologies. Attendees will be exposed to the latest technological breakthroughs in medicine and healthcare. 4. BioInnovation Stadium: This is the best stage for biomedical innovations! Through a series of presentations and discussions presented by leading biomedical innovators from Israel, Australia, US, France, Korea and Singapore, attendees will be immersed in a world of opportunities to make impacts. From technologies that disrupt current care models to innovations that accelerate the advancement of medicine, you will discover endless business opportunities.
 Exhibitor Highlights: 1.World-class medical institutes and advanced medical technologies 2. Leading IT, ICT, electronics and tech giants & comprehensive digital healthcare supply chain 3. Innovative medical AI, IoT and robotic technologies 4.  High-quality bio-pharmaceutical R&D, CDMO and CMO companies 5. Efficient genetic testing, laboratory services and solutions 6. New business models for preventive medicine and healthcare management
 Med x Tech Summit Asia: 1.Keynote Speakers: Hitachi、IBM Watson Health、illumina、Nvidia、Microsoft、Google & Verily、Merck、Novartis、Teva、Takeda、Bluebird Bio、Nebula Genomics 2. CEO Forum: Global industry leaders will discuss the future trends of the healthcare industry from various perspectives. Opportunities and strategies for biomedical developments and investments will be explored in depth. 3. Intelligent Healthcare Conference: This international conference gathers world-leading professionals from different industries, government, and academia to explore the unprecedented power of interdisciplinary collaborations between medicine and technologies. Attendees will be exposed to the latest technological breakthroughs in medicine and healthcare. 4. BioInnovation Stadium: This is the best stage for biomedical innovations! Through a series of presentations and discussions presented by leading biomedical innovators from Israel, Australia, US, France, Korea and Singapore, attendees will be immersed in a world of opportunities to make impacts. From technologies that disrupt current care models to innovations that accelerate the advancement of medicine, you will discover endless business opportunities.
 

Speakers

CEO Prospectives

 

Murakami Sei, GM of Industry & Distribution Business Unit, Hitachi

Birgit Reitmaier, Head of Access to Innovation APAC, 
Merck

 Larry Merisalde, GM of Greater China and Vietnam, Teva

 Eunice Chiu, VP Sales and GM Taiwan, NVIDIA

 Harry Yang, VP&GM of Medical Devices Group. Qisda


Immuno-Oncology and Next Generation Biotherapeutics

 

 Seigo Izumo, SVP, Takeda Pharma.

 Wise Young, Chief Science & Medical Advisor, StemCyte

 David DiGiusto, CTO, Semma Therapeutics

ony J Wang, Co-Director, Center for Radiosurgery, Columbia University Medical Center

 Trevor Martin, Cofounder & CEO, Mammoth Biosciences

Chris Shu, Managing Partner, Pacific 8 Ventures


Delivering Personalized Healthcare through Precision Medicine

 

 Liang-Yeu Lenny Chen, Clinical Adoption Specialist - Manager & Asian Pacific Leader, IBM Watson Health

 Alireza Haghighi,President of Advancement Initiative for Medicine and Science, Harvard Medical School

 Colin Collins, Director of Laboratory for Advanced Genome Analysis, Vancuvar Prostate Center


Blockchain and Electronic Health Security in Healthcare

 

 Mohammed Tayeb, Co-founder & COO, Medicalchain

 Alexandra Tinsman, Regional Head, North America, NEM Foundation

 Emma Hossack, CEO, Extensia


Designing an Intelligent Healthcare Ecosystem

 

 Keren Priyadarshini, Regional Business Leader, Microsoft

 Vitaly Herasevich, Associate Professor of Department of Anesthesiology and Perioperative Medicine, Division of Critical Care, Mayo Clinic

 David Hansen, CEO of Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation (CSIRO)

 Daniel Tse, Product Manager, Google AI


BioInnovation Stadium: From Entrepreneurship to Ecosystem

 

 Markus Kalousek, VP of Pharma Head Search & Evaluation (Global BD&L), Novartis

 Yonghui Shi, Managing Principal of Medtronic China Venture Fund

 Dan Wang, Head of Asia Pacific, Johnson & Johnson Innovation

 Karin Mayer Rubinstein, CEO & President, Israel Advanced Technology Industries (IATI)

 Dan Shwarzman,CEO, MindUP (Israel)

 Yarom Cohen, CEO, Met-Syn-Lys (Israel)

 Robert C. Henke, PhD, Area Director Asia Pacific, Yourgene Health (UK)

 Francis Chen, CEO, Soterawireless (US)

 James Reeve, eHealth Business Consultant, Venture Wise (AU)

 Anshul Dayal, Co-Founder & CTO, Neuromersiv (AU)

 Philip Gregory, Managing Director, China, George Clinical (AU)


Singapore Biotechnology Ecosystem

 

 Yan Lin Lye, VP Business Development (Asia) , Cambridge Consultants

 Whye Kei Lye, Director of Business Development (Future Health Care), Nanyang Technological University

 Johnson Chen, Founder & CEO, CapBridge/ClearBridge

 Hsien-Hui Tong , Head, Venture Investing, SGInnovate (Lunch will be provided)

 B2B Partnering: Online partnering system to search for and arrange meetings with exhibitors in advance. Search for potential partners and pre-schedule appointments.
 Why Taiwan: In this digital era, the global health industry is currently undergoing a revolutionary transformation process, and Taiwan has unique advantages in contributing a significant part to this transformation: 1. Advanced Medical Specialties- Taiwan's world-class medical centers consistently offer exceptional niche medical services, with notable achievements in multiple specialties, including liver transplant, reconstructive surgery, reproductive health, minimally invasive surgery, and treatment of lung cancer. Taiwan's medical centers even serve as the training centers of choice across Asia for various specialties and procedures. 2. World's Tech Supply Chain- Taiwan serves as the heart of the world’s tech supply chain, offering high-quality products from IC design, semiconductor, to electronics. Taiwan's leading IT and electronics manufacturers have been supplying products to multinational tech corporates for decades. Now they are the key drivers of healthcare innovation, accelerating AI, IoT and robotic applications for the entire healthcare and biomedical industry. 3. New Drug Development- Taiwan's pharmaceutical R&D and manufacturing capabilities are of international standards. Currently there are multiple FDA approved new drugs for the treatment of AIDS, pancreas cancer, kidney disease, and infectious disease that were developed in Taiwan - making Taiwan a leader in Asia's new drug development.
 B2B Partnering: Online partnering system to search for and arrange meetings with exhibitors in advance. Search for potential partners and pre-schedule appointments.
 Why Taiwan: In this digital era, the global health industry is currently undergoing a revolutionary transformation process, and Taiwan has unique advantages in contributing a significant part to this transformation: 1. Advanced Medical Specialties- Taiwan's world-class medical centers consistently offer exceptional niche medical services, with notable achievements in multiple specialties, including liver transplant, reconstructive surgery, reproductive health, minimally invasive surgery, and treatment of lung cancer. Taiwan's medical centers even serve as the training centers of choice across Asia for various specialties and procedures. 2. World's Tech Supply Chain- Taiwan serves as the heart of the world’s tech supply chain, offering high-quality products from IC design, semiconductor, to electronics. Taiwan's leading IT and electronics manufacturers have been supplying products to multinational tech corporates for decades. Now they are the key drivers of healthcare innovation, accelerating AI, IoT and robotic applications for the entire healthcare and biomedical industry. 3. New Drug Development- Taiwan's pharmaceutical R&D and manufacturing capabilities are of international standards. Currently there are multiple FDA approved new drugs for the treatment of AIDS, pancreas cancer, kidney disease, and infectious disease that were developed in Taiwan - making Taiwan a leader in Asia's new drug development.